- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS)
This study is testing a new medicine, SAR442168, for people with Primary Progressive Multiple Sclerosis (PPMS). It's comparing the new medicine to a dummy pill to see if it can slow down the disease's progress and if it's safe to use.
For: Primary Progressive Multiple SclerosisBelgium · France · Austria - Active not recruitingPHASE3
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
This study looks at the everyday safety and how well a drug called tolebrutinib is tolerated over a long time. It's for adults with different types of multiple sclerosis (MS) who have already been in earlier tolebrutinib studies.
For: Relapsing Multiple Sclerosis · Secondary Progressive Multiple Sclerosis · Progressive Relapsing Multiple SclerosisUnited States · Argentina · Australia